Literature DB >> 22441970

Patient rated outcomes and survivorship following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS + HIPEC).

Katharine E Duckworth1, Richard P McQuellon, Gregory B Russell, Craig S Cashwell, Perry Shen, John H Stewart, Edward A Levine.   

Abstract

BACKGROUND: Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS + HIPEC) is a treatment combining cytoreductive surgery with hyperthermic chemotherapy directly into the peritoneal cavity. Recipients may gain extended life when compared with best supportive care; yet results often are achieved with substantial morbidity and health-related quality of life (HRQOL) deficits. The purpose of this study was to record patient rated outcomes and the HRQOL of long-term survivors.
METHODS: One hundred and two patients living 12+ months post-treatment completed a survey including the Medical Outcomes Study 36-item Short Form Health Survey (SF-36), Functional Assessment of Cancer Therapy-Colon (FACT-C), and Pittsburgh Sleep Quality Index.
RESULTS: SF-36 Physical Component scores were significantly lower than general population norms (46.7, z= -2.943, P=0.003), while Mental Component scores were significantly higher (53.6, z=4.208, P ≤ 0.001). FACT scores were higher than general FACT normative scores. The majority (56%) of these survivors reported significant sleep quality impairment.
CONCLUSION: Although most HRQOL scores were comparable to or higher than those of the general population, long-term physical and functional deficits remain. These deficits, along with the poor sleep quality of recipients, may be improved by survivorship programs or targeted psychosocial interventions.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22441970      PMCID: PMC3668777          DOI: 10.1002/jso.23089

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  18 in total

1.  The challenge of response shift for quality-of-life-based clinical oncology research.

Authors:  M A Sprangers; C E Schwartz
Journal:  Ann Oncol       Date:  1999-07       Impact factor: 32.976

Review 2.  Assessing meaningful change in quality of life over time: a users' guide for clinicians.

Authors:  Mirjam A G Sprangers; Carol M Moinpour; Timothy J Moynihan; Donald L Patrick; Dennis A Revicki
Journal:  Mayo Clin Proc       Date:  2002-06       Impact factor: 7.616

Review 3.  Health-related quality of life and cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy.

Authors:  Richard McQuellon; Katie E Duckworth
Journal:  Curr Probl Cancer       Date:  2009 May-Jun       Impact factor: 3.187

4.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

Review 5.  Insomnia in the context of cancer: a review of a neglected problem.

Authors:  J Savard; C M Morin
Journal:  J Clin Oncol       Date:  2001-02-01       Impact factor: 44.544

6.  Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis.

Authors:  Richard P McQuellon; Brian W Loggie; Anna B Lehman; Gregory B Russell; Ronald A Fleming; Perry Shen; Edward A Levine
Journal:  Ann Surg Oncol       Date:  2003-03       Impact factor: 5.344

7.  Associations of frequent sleep insufficiency with health-related quality of life and health behaviors.

Authors:  Tara W Strine; Daniel P Chapman
Journal:  Sleep Med       Date:  2005-01       Impact factor: 3.492

8.  The Posttraumatic Growth Inventory: measuring the positive legacy of trauma.

Authors:  R G Tedeschi; L G Calhoun
Journal:  J Trauma Stress       Date:  1996-07

9.  The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

Authors:  D F Cella; D S Tulsky; G Gray; B Sarafian; E Linn; A Bonomi; M Silberman; S B Yellen; P Winicour; J Brannon
Journal:  J Clin Oncol       Date:  1993-03       Impact factor: 44.544

10.  The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research.

Authors:  D J Buysse; C F Reynolds; T H Monk; S R Berman; D J Kupfer
Journal:  Psychiatry Res       Date:  1989-05       Impact factor: 3.222

View more
  7 in total

Review 1.  Intraperitoneal chemotherapy from Armstrong to HIPEC: challenges and promise.

Authors:  Ramez N Eskander; James Cripe; Robert E Bristow
Journal:  Curr Treat Options Oncol       Date:  2014-03

2.  Quality-of-Life Evaluation After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.

Authors:  Rebecca M Dodson; Richard P McQuellon; Harveshp D Mogal; Katharine E Duckworth; Gregory B Russell; Konstantinos I Votanopoulos; Perry Shen; Edward A Levine
Journal:  Ann Surg Oncol       Date:  2016-09-08       Impact factor: 5.344

3.  Caregiver Quality of Life Before and After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Authors:  Katharine E Duckworth; Richard P McQuellon; Gregory B Russell; Kathleen C Perry; Chandylen Nightingale; Perry Shen; Konstantinos I Votanopoulos; Bonny Morris; Edward A Levine
Journal:  J Am Coll Surg       Date:  2020-01-31       Impact factor: 6.113

Review 4.  Palliative cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion: current clinical practice or misnomer?

Authors:  Laura A Lambert; Ariana Harris
Journal:  J Gastrointest Oncol       Date:  2016-02

Review 5.  Organ-Specific Adverse Effects After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.

Authors:  Rogini Balachandran; Louise Zinck Mogensen; Peter Christensen; Henriette Vind Thaysen; Lene Hjerrild Iversen
Journal:  Ann Surg Oncol       Date:  2022-02-25       Impact factor: 4.339

6.  Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients.

Authors:  Edward A Levine; John H Stewart; Perry Shen; Gregory B Russell; Brian L Loggie; Konstantinos I Votanopoulos
Journal:  J Am Coll Surg       Date:  2013-12-21       Impact factor: 6.113

7.  Clinicopathological analysis of appendiceal mucinous tumors: A single-center experience.

Authors:  Arif Emre; Mehmet Sertkaya; İlhami Taner Kale
Journal:  Turk J Surg       Date:  2017-12-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.